On the basis of the numerous biological functions of DPP-4, some preclinical studies have shown a potential link between DPP-4 inhibitors and cancer progression-related processes, including cancer growth [15], metastasis [16], and chemotherapeutic resistance [17]. This evidence concerns the gene DPP4 and cancer.